ClinicalTrials.govpublic full text
HCC Risk and Monitoring in Patients With Type 2 Diabetes
type 2 diabetes (t2dm), hepatocellular carcinoma (hcc), type 2 diabetes, liver cancer, surveillance, prospective randomized study, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 914772
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.